These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 4361201)
1. Diabetes and hypertensive vascular disease. Mechanisms and treatment. Christlieb AR Am J Cardiol; 1973 Sep; 32(4):592-606. PubMed ID: 4361201 [No Abstract] [Full Text] [Related]
2. Sympathetic nervous system, diabetes, and hypertension. Perin PC; Maule S; Quadri R Clin Exp Hypertens; 2001; 23(1-2):45-55. PubMed ID: 11270588 [TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin-aldosterone system in diabetes mellitus. Christlieb AR Diabetes; 1976; 25(2 SUPPL):820-5. PubMed ID: 823063 [TBL] [Abstract][Full Text] [Related]
4. The pathophysiology of renin. Berman LB; Vertes V Clin Symp; 1973; 25(5):1-35. PubMed ID: 4358471 [No Abstract] [Full Text] [Related]
5. [Renin-angiotensin system and hypertension. Morphology and function of the secretorily insufficient juxtaglomerular apparatus]. Helmchen U; Dienemann H; Kneissler U; Stahl R; Kirchertz EJ Verh Dtsch Ges Kreislaufforsch; 1977; 43():138-44. PubMed ID: 613559 [No Abstract] [Full Text] [Related]
6. [Hypertension in diabetes mellitus. Causes, follow-up and treatment]. Klaus D Med Klin (Munich); 1994 Jun; 89(6):330-8. PubMed ID: 8072457 [No Abstract] [Full Text] [Related]
7. The contribution of the sympathetic nervous system to hypertension in diabetes mellitus. Kribben A; Philipp T Diabete Metab; 1989; 15(5 Pt 2):313-7. PubMed ID: 2693150 [TBL] [Abstract][Full Text] [Related]
8. [The reinin- angiotensin-aldosterone system in essential and renovascular hypertension]. Tronchetti F; Romanelli R; Materazzi F; Cella PL; Salvetti A Pathol Biol; 1968 May; 16(9):575-81. PubMed ID: 4300851 [No Abstract] [Full Text] [Related]
9. [Renal sequelae of sympathetic hyperactivity]. Watschinger B; Habicht A Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546 [No Abstract] [Full Text] [Related]
10. Hypertension and secondary hyperaldosteronism associated with a renin-secreting renal juxtaglomerular-cell tumour. Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Tree M; Bell PR; Davidson JK; Ruthven IS Lancet; 1973 Dec; 2(7840):1228-32. PubMed ID: 4128560 [No Abstract] [Full Text] [Related]
11. The reno-cardiovascular connection in the patient with Diabetes mellitus: What's new? Palau V; Riera M; Soler MJ Endocrinol Diabetes Nutr; 2017 May; 64(5):237-240. PubMed ID: 28495318 [No Abstract] [Full Text] [Related]
12. [Control of arterial pressure in diabetic nephropathy]. Luño J; García de Vinuesa S Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304 [No Abstract] [Full Text] [Related]
14. [Modulation of renin-angiotensin system for vascular protection in hypertensive patients and in patients with diabetic nephropathy]. Gómez-Fernández P Rev Clin Esp; 2004 Nov; 204(11):596-600. PubMed ID: 15511408 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. Benter IF; Yousif MH; Dhaunsi GS; Kaur J; Chappell MC; Diz DI Am J Nephrol; 2008; 28(1):25-33. PubMed ID: 17890855 [TBL] [Abstract][Full Text] [Related]
16. Relation of renal arterial pressure to activity of renin-angiotensin system in renal hypertension. Koletsky S; Rivera-Velez JM; Marsh DG; Pritchard WH Proc Soc Exp Biol Med; 1967 May; 125(1):96-100. PubMed ID: 4290949 [No Abstract] [Full Text] [Related]
17. Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes. Hartner A; Cordasic N; Klanke B; Wittmann M; Veelken R; Hilgers KF Am J Physiol Renal Physiol; 2007 Feb; 292(2):F820-7. PubMed ID: 17018847 [TBL] [Abstract][Full Text] [Related]